Rare diseases: what applications and prospects for AI? – news- Pharmaceuticals

Rare diseases what applications and prospects for AI news

Our events 09/22/2022 A patient suffering from a rare disease experiences an average diagnostic delay of four years. Faced with this unacceptable observation, participants in the second PharmaHealthTech round table have developed tools that use artificial intelligence to reduce this wandering and improve the journey of the patients affected. 95% of the 7,000 to 8,000 … Read more

Madrigal Pharmaceuticals, Inc. prsente les dernires donnes de phase 3 sur la NASH et plusieurs rsums oraux au congrs international sur le foie de l’EASL&#1414153 ; | Zone bourse

Huntington Ingalls Industries Inc nomme Jeff Jackson au poste de

Madrigal Pharmaceuticals, Inc. a annonc les donnes de plusieurs rsums de resmetirom prsents au Congrs international du foie de l’Association europenne pour l’tude du foie (EASL 2022), y compris une prsentation tardive des donnes de l’tude de phase 3 MAESTRO-NAFLD-1 et trois prsentations orales supplmentaires du programme … Read more

» Qubit Pharmaceuticals raises €16 million to deploy its quantum physics-based drug discovery platform MyPharma Editions

Qubit Pharmaceuticals raises E16 million to deploy its quantum

Posted on Thursday, June 23, 2022 Qubit Pharmaceuticals, a deeptech company specializing in simulation and molecular modeling through the use of quantum physics, has just announced the completion of a funding round of 16.1 million euros from the funds XAnge, Omnes, Quantonation and Mr. Octave Klaba, founder of OVH. This seed round, which brings together … Read more

How Qubit Pharmaceuticals plans to accelerate new drug discovery with quantum

How Qubit Pharmaceuticals plans to accelerate new drug discovery with

The arrival, in the next five years, of the quantum computer capable of multiplying the current computing power, could revolutionize many sectors, in particular that of health. And create new world champions, perhaps like Qubit Pharmaceuticals, which announced on June 10 the success of a fundraising of 16 million euros from the funds XAnge, Omnes, … Read more

Boost for Future4care – news- Pharmaceuticals

Boost for Future4care news Pharmaceuticals

Ecosystem 05/17/2022 Future4care, an e-health accelerator, inaugurated yesterday, Monday May 16, its 6,500 m2 campus in the 13th arrondissement of Paris, in the presence of the 22 start-ups of its first promotion, the leaders of the four major founding international groups and many guests. Launched in June 2021 by Capgemini, Generali, Orange and Sanofi, Future4care … Read more

Iktos announces a collaboration with Ono Pharmaceuticals for the design of new drugs using artificial intelligence

Iktos announces a collaboration with Ono Pharmaceuticals for the design

Iktos, a company specializing in Artificial Intelligence (AI) for the design of new drugs, announced on March 30 a collaboration agreement with Ono Pharmaceuticals, a Japanese pharmaceutical company focused on R&D which focuses on the innovation of drugs dedicated to the fight against disease and pain. Ono’s research team will have direct access to Iktos’ … Read more